Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects

NCT02070939 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-06260414
DRUG: Placebo
DRUG: PF-06260414
DRUG: Placebo
DRUG: PF-06260414
DRUG: Placebo

Sponsor

Pfizer